Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting

• Main Authors: Masahiro Hatori (Author), Kazuyoshi Kawakami (Author), Takeru Wakatsuki (Author), Eiji Shinozaki (Author), Kazuo Kobayashi (Author), Takeshi Aoyama (Author), Yasuhiro Nakano (Author), Kenichi Suzuki (Author), Kensei Yamaguchi (Author), Toshihiro Hama (Author)
• Format: Book
• Published: SAGE Publishing, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The association between regorafenib dosage in the treatment of metastatic colorectal cancer (mCRC) and efficacy is currently not well established. It was previously reported that the regorafenib dose as prescribed is associated with efficacy, but doses in actual clinical settings have not been analy...